{"title":"[Guidelines for diagnosis and treatment of late-onset hypogonadism in males].","authors":"","doi":"10.3760/cma.j.cn112137-20241206-02758","DOIUrl":null,"url":null,"abstract":"<p><p>Late-onset hypogonadism (LOH) refers to the decline in serum testosterone levels in middle-aged and elderly men with aging, causing symptoms such as decreased libido, erectile dysfunction, and reduced physical and mental activity, as well as metabolic abnormalities such as abdominal obesity, diabetes and myopenia. The diagnosis and treatment of LOH are closely related to the health and quality of life of middle-aged and elderly men. It has been a focus of medical attention. The clinical data over the past decade provide substantial evidence for these issues. Consequently, Growth and Development and Gonadal Diseases Committee of Chinese Aging Well Association organized 52 experts in endocrinology, andrology, urology, geriatrics, traditional Chinese medicine, nutrition, laboratory medicine, cardiology, neurology, psychiatrics, hematology, orthopedics, basic medicine, pharmacology and othe fields. Based on the Oxford Center for Evidence-Based Medicine's level of clinical evidence and recommendation levels, the guidelines have been developed around the diagnosis of LOH, the risks and benefits of testosterone supplementation. Combined with the evaluation opinions of Delphi method, 17 recommendations were finally formulated to help clinicians cope with LOH.</p>","PeriodicalId":24023,"journal":{"name":"Zhonghua yi xue za zhi","volume":"105 9","pages":"650-660"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhonghua yi xue za zhi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112137-20241206-02758","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Late-onset hypogonadism (LOH) refers to the decline in serum testosterone levels in middle-aged and elderly men with aging, causing symptoms such as decreased libido, erectile dysfunction, and reduced physical and mental activity, as well as metabolic abnormalities such as abdominal obesity, diabetes and myopenia. The diagnosis and treatment of LOH are closely related to the health and quality of life of middle-aged and elderly men. It has been a focus of medical attention. The clinical data over the past decade provide substantial evidence for these issues. Consequently, Growth and Development and Gonadal Diseases Committee of Chinese Aging Well Association organized 52 experts in endocrinology, andrology, urology, geriatrics, traditional Chinese medicine, nutrition, laboratory medicine, cardiology, neurology, psychiatrics, hematology, orthopedics, basic medicine, pharmacology and othe fields. Based on the Oxford Center for Evidence-Based Medicine's level of clinical evidence and recommendation levels, the guidelines have been developed around the diagnosis of LOH, the risks and benefits of testosterone supplementation. Combined with the evaluation opinions of Delphi method, 17 recommendations were finally formulated to help clinicians cope with LOH.
晚发性性腺功能减退症(LOH)是指中老年男性随着年龄的增长,血清睾酮水平下降,引起性欲减退、勃起功能障碍、体力和脑力活动减少等症状,以及腹型肥胖、糖尿病、肌营养不良等代谢异常。LOH的诊断和治疗与中老年男性的健康和生活质量密切相关。它一直是医学界关注的焦点。过去十年的临床数据为这些问题提供了大量证据。因此,中国老年保健协会生长发育与性腺疾病专业委员会组织了内分泌科、泌尿外科、老年病科、中医科、营养科、检验科、心内科、神经内科、精神科、血液科、骨科、基础医学、药理学等领域的52位专家。根据牛津循证医学中心(Oxford Center for Evidence-Based Medicine)的临床证据等级和推荐等级,围绕 LOH 的诊断、补充睾酮的风险和益处制定了指南。结合德尔菲法的评估意见,最终制定了17条建议,以帮助临床医生应对LOH。